John E. Kao Sells 90,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao sold 90,000 shares of the business’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $14.23, for a total transaction of $1,280,700.00. Following the completion of the sale, the chief executive officer now directly owns 2,183,100 shares of the company’s stock, valued at approximately $31,065,513. The trade was a 3.96 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Alignment Healthcare Stock Down 1.4 %

ALHC stock opened at $13.68 on Friday. The company has a market cap of $2.62 billion, a PE ratio of -17.77 and a beta of 1.50. The business has a 50-day simple moving average of $12.95 and a 200 day simple moving average of $11.59. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $15.82. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Stifel Nicolaus boosted their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, January 14th. Stephens reissued an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 2nd. Barclays boosted their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Finally, UBS Group boosted their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average target price of $11.88.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. R Squared Ltd acquired a new position in Alignment Healthcare during the fourth quarter worth about $55,000. nVerses Capital LLC acquired a new position in Alignment Healthcare during the third quarter worth about $95,000. RiverPark Advisors LLC acquired a new position in Alignment Healthcare during the fourth quarter worth about $106,000. Tower Research Capital LLC TRC raised its stake in Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after acquiring an additional 6,286 shares in the last quarter. Finally, Ballentine Partners LLC acquired a new position in Alignment Healthcare during the fourth quarter worth about $121,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.